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Abstract 
The growth plate provides a substantial source of mesenchymal cells in the endosteal 
marrow space during endochondral ossification. The current model postulates that a 
group of chondrocytes in the hypertrophic zone can escape from apoptosis and transform 
into cells that eventually become osteoblasts in an area beneath the growth plate. The 
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growth plate is composed of cells with various morphologies; particularly, at the 
periphery of the growth plate immediately adjacent to the perichondrium are ‘borderline’ 
chondrocytes, which align perpendicularly to other chondrocytes. However, in vivo cell 
fates of these special chondrocytes have not been revealed. Here we show that borderline 
chondrocytes in growth plates behave as transient mesenchymal precursor cells for 
osteoblasts and marrow stromal cells. A single cell RNA-seq analysis revealed 
subpopulations of Col2a1-creER-marked neonatal chondrocytes and their cell-type 
specific markers. A tamoxifen pulse to Pthrp-creER mice in the neonatal stage (before 
the resting zone was formed) preferentially marked borderline chondrocytes. Following 
the chase, these cells marched into the nascent marrow space, expanded in the 
metaphyseal marrow and became Col(2.3kb)-GFP+ osteoblasts and Cxcl12-GFPhigh 
reticular stromal ‘CAR’ cells. Interestingly, these borderline chondrocyte-derived marrow 
cells were short-lived, as they were significantly reduced during adulthood. These 
findings demonstrate based on in vivo lineage-tracing experiments that borderline 
chondrocytes in the peripheral growth plate are a particularly important route for 
producing osteoblasts and marrow stromal cells in growing murine endochondral bones. 
A special microenvironment neighboring the osteogenic perichondrium might endow 
these chondrocytes with an enhanced potential to differentiate into marrow mesenchymal 
cells. 
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Introduction 
Growth of bones and their marrow space requires a constant supply of 
mesenchymal cells to build the new stromal compartment. The growth plate can provide 
a substantial source of mesenchymal cells in endochondral ossification, which has been 
supported by a series of murine lineage-tracing studies using cre/creER transgenes active 
in chondrocytes and their close relatives, such as Sox9-creER, type II collagen (Col2)-
creER, aggrecan (Acan)-creER, type X collagen (Col10)-cre/creER(1-3). Our lineage-
tracing study using a Pthrp-creER line demonstrated that PTHrP+ resting chondrocytes 
can establish columnar chondrocytes, some of which can further differentiate into 
osteoblasts and marrow stromal cells through chondrocyte-to-osteoblast transformation(4). 
However, these columnar chondrocytes of the central growth plate can contribute only to 
a minor fraction of marrow mesenchymal cells in adulthood; therefore, chondrocytes in 
other locations may contribute more significantly in earlier stages. ‘Borderline’ 
chondrocytes at the periphery of the growth plate in a special microenvironment 
immediately adjacent to the perichondrium(5) can produce osteoblast-like cells in cultured 
conditions. In this study, we set out to reveal cellular heterogeneity of neonatal 
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chondrocytes by a single cell RNA-seq analysis, and in vivo cell fates of borderline 
chondrocytes by taking advantage of a Pthrp-creER line.  
Materials and Methods 
Mice. 
Pthrp-creER(4), Cxcl12GFP/+(6) mice have been described elsewhere. 
Col1a1(2.3kb)-GFP (JAX013134), Col2a1-creER (JAX006774), Rosa26-CAG-loxP-
stop-loxP-tdTomato (Ai14: R26R-tdTomato, JAX007914) mice were acquired from the 
Jackson laboratory. FVB/N mice were acquired from the Charles River Laboratories. All 
procedures were conducted in compliance with the Guidelines for the Care and Use of 
Laboratory Animals approved by the University of Michigan’s Institutional Animal Care 
and Use Committee (IACUC), protocol 7681 (Ono) and the ARRIVE (Animal Research: 
Reporting of In Vivo Experiments) guidelines. All mice were housed in a specific 
pathogen-free condition, and analyzed in a mixed background. For neonatal experiments, 
tamoxifen (Sigma T5648) or 4-hydroxytamoxifen (4-OHT, Sigma H6278) was dissolved 
in sunflower seed oil (Sigma S5007) and injected intraperitoneally (0.125 – 0.25mg) 
shortly after birth. For prenatal experiments, tamoxifen and progesterone (Sigma P3972) 
were dissolved and injected intraperitoneally (4mg each) at an indicated embryonic day. 
Mice were used for analysis regardless of the sex. No statistical method was used to 
predetermine sample size. Sample size was determined on the basis of previous literature 
and our previous experience to give sufficient standard deviations of the mean so as not 
to miss a biologically important difference between groups. The experiments were not 
randomized. All of the available mice of the desired genotypes were used for 
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experiments. The investigators were not blinded during experiments and outcome 
assessment. One femur from each mouse was arbitrarily chosen for histological analysis. 
Genotypes were not particularly highlighted during quantification. 
Histology. 
Frozen sections were prepared using a cryostat (Leica CM1850) and adhered on 
positively charged glass slides (Fisherbrand ColorFrost Plus). Sections were stained with 
anti-active Caspase-3 polyclonal (1:250; Promega PR-G7481), anti-Runx2 polyclonal 
(1:100; Novus Biologicals NBP1-89104) or anti-Fra1 polyclonal (1:100; Invitrogen PA5-
40361) antibodies overnight at 4oC, followed by staining with appropriate Alexa Fluor 
488/647-conjugated secondary antibodies for 3 hours at 4oC and DAPI (4’,6-diamidino-
2-phenylindole, 5µg/ml, Invitrogen D1306). In situ hybridization was performed with 
RNAscope 2.5 HD Reagent kit Brown (Advanced Cell Diagnostics 322300) using 
following probes: Col2a1 (407221), Acan (439101) and Col10a1 (426181) according to 
the manufacturer’s protocol. Sections were analyzed using an automated inverted 
fluorescence microscope with a structured illumination system (Zeiss Axio Observer Z1 
with ApoTome.2 system). Images were typically tile-scanned with a motorized stage, Z-
stacked and reconstructed by a maximum intensity projection (MIP) function. 
Differential interference contrast (DIC) was used for objectives higher than 10x. Serial 
sections spanning over 1mm thickness (up to 20 sections) of distal femurs were used for 
cell quantification. 
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Single cell RNA-seq analysis. 
Femur growth plate cells were dissociated enzymatically (Sigma/Roche, Liberase 
TM) and loaded onto a five laser BD FACSAriaIII high-speed cell sorter with a 100µm 
nozzle. Approximately 18,000 tdTomato+ cells were loaded onto 10X Genomics 
Chromium 3’ Single Cell Gene Expression Solution v3 (10X Genomics Inc., Pleasanton, 
CA) microfluidics chip. The 10X Cell Ranger output matrix file was analyzed by Seurat 
R package(7) with cell cycle regression. For alignment purposes, we used a custom 
genome fasta and index file by including the sequences of tdTomato-WPRE (woodchuck 
hepatitis virus post-transcriptional regulatory element, a 3’UTR of the tdTomato 
sequence) to the mouse genome (mm10). The single cell dataset discussed in this 
publication are accessible in the NCBI’s Gene Expression Omnibus under accession 
number GSE125464. 
Results 
Single cell RNA-seq characterization of neonatal growth plate chondrocytes 
 Col2a1-creER marks a group of early skeletal progenitors in growing bones 
during the perinatal stage(2). A tamoxifen pulse to Col2a1-creER; R26RtdTomato mice at P0 
predominantly marked chondrocytes at the periphery of the growth plate, including those 
termed as borderline chondrocytes located immediately adjacent to the perichondrium, 
shortly after tamoxifen injection at P2 (Fig. 1A). After a week of chase at P7, these 
chondrocytes continued to occupy the periphery of the growth plate in a borderline-
enriched manner (Fig. 1B, arrows), and their descendants contributed to well-defined 
reverse triangular areas adjacent to the metaphyseal endosteal surface (Fig. 1B, 
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arrowheads). Therefore, Col2a1-creER can mark a group of chondrocytes including 
precursors for borderline chondrocytes in the neonatal growth plate, which further 
contribute to mesenchymal cells in the marrow space. 
 We utilized a single cell RNA-seq analysis to define the characteristics of 
borderline chondrocytes. Flow cytometry analysis of cells dissociated from Col2a1-
creER; R26RtdTomato femur growth plates at P2 (pulsed at P0) revealed that tdTomato+ 
cells accounted for approximately two-thirds of harvested cells (Fig. 1C). We 
subsequently profiled 8,486 Col2a1CE-tdTomato+ single cells isolated by fluorescence-
activated cell sorting (FACS) using the 10X Genomics Chromium platform. An initial t-
distributed stochastic neighbor embedding (t-SNE) analysis revealed 11 clusters (Fig. 
1D). Of the 9 clusters of interest, we discovered three clusters of column-forming 
chondrocytes in the lower zone growth plate abundant in Acan (Cluster 0,5,7), two 
clusters of chondrocytes in the upper zone growth plate abundant in Ucma (Cluster 
1,3)(8,9) and two cluster of cells in the articular surface abundant in Prg4 (Cluster 2,6)(10) 
(Fig. 1D, Fig.S1A). Interestingly, chondrocytes in Cluster 8 were abundant in tdTomato-
WPRE and exhibited a borderline state between the upper and lower zone growth plate; 
their cell-type specific markers included Srxn1, Ifrd1, Tnfrsf12a, Fosl1, Pmepa1 and Myc 
(Fig.S1B). These cells expressed genes encoding secreted factors Pthlh (Pthlh is also 
known as Pthrp) and Cxcl14, but not Ihh, Grem1 or Cxcl12 (Fig.S1A,C) Histological 
validation of an identified marker revealed that FOSL1 (also knowns as Fra1) was indeed 
expressed at a particularly high level by tdTomatobright chondrocytes at the periphery of 
the growth plate (Fig. 1E). Moreover, these cells did not express hypertrophic markers 
This article is protected by copyright. All rights reserved. 
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Col10a1 or Sp7 (Fig.S1D). Therefore, these analyses reveal fundamental transcriptional 
heterogeneity and cellular diversity of neonatal growth plate chondrocytes. 
Pthrp-creER specifically marks borderline chondrocytes in the fetal and neonatal stage 
PTHrP is initially expressed in the periarticular region of the fetal and neonatal 
growth plate, and later in the resting zone of the postnatal growth plate(4).  
First, we set out to determine cell fates of fetal PTHrP+ cells by in vivo lineage-
tracing experiments. We injected tamoxifen to Pthrp-creER; R26RtdTomato mice carrying 
Cxcl12GFP/+ reporter at embryonic day 12.5 (E12.5) and analyzed these mice at postnatal 
day 9 (P9) (Fig.S2A). The descendant of PTHrP+ periarticular cells at E12.5 (PTHrPCE-
E12.5 cells) became a small number of cells on the metaphyseal endosteal region 
(Fig.S2B). Second, we pulsed these mice at later fetal stages at E14.5 or E17.5. Both 
PTHrPCE-E14.5 and PTHrPCE-E17.5 cells became cells on the metaphyseal endosteal 
region, Cxcl12-GFPhigh stromal cells in the metaphyseal marrow space and cells on the 
articular surface (Fig.S2C,D). Therefore, Pthrp-creER marks precursors for metaphyseal 
marrow mesenchymal cells during the fetal stage, while also marking precursors for 
articular chondrocytes in later fetal stages. These precursors might reside in the 
perichondrium, therefore representing a discrete population from borderline 
chondrocytes.  
Second, we pulsed Pthrp-creER; R26RtdTomato mice carrying Col1(2.3kb)-GFP 
reporter at birth (postnatal day 0, P0) and analyzed these mice at 48 hours later at P2. A 
small number of chondrocytes at the periphery of the growth plate, including ‘borderline 
chondrocytes’ adjoining the perichondrium, was marked by tdTomato (PTHrPCE-P0 cells, 
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25.6±5.8 tdTomato+ cells per growth plate) (Fig. 2A). These PTHrPCE-P0 cells were 
localized within the cartilage, expressing type II collagen (Col2a1) (18/18 tdTomato+ 
cells examined, 100%) and aggrecan (Acan) (21/23 tdTomato+ cells examined, 91%); 
some of them also expressed type X collagen (Col10a1) mRNAs (4/25 tdTomato+ cells 
examined, 16%) (Fig. 2B-D). PTHrPCE-P0 cells underwent apoptosis less frequently; 
only a small fraction of these tdTomato+ cells were positive for activated Caspase 3 
(4.4±8.8% of PTHrPCE-P0 cells, in contrast to 27.0±8.2% of hypertrophic chondrocytes) 
(Fig. 2E, Fig.S3A). These tdTomato+ cells were embedded in the cartilaginous matrix, 
with a fraction of them expressing transcription factors RUNX2 (13.8±10.5%) (Fig. 2F, 
Fig.S3B). Following the chase, PTHrPCE-P0 cells started to move into the metaphyseal 
marrow space (Fig.S3C, Fig. 2G). To determine the cell cycle status of tdTomato+ 
peripheral chondrocytes, we performed an EdU label-exclusion assay. Pthrp-creER; 
R26R-tdTomato mice were first pulsed with tamoxifen at P0, then serially pulsed with 
EdU for three days and analyzed at P3. A great majority of tdTomato+ cells were resistant 
to EdU incorporation (Fig.S3D, EdU+; 4.6±4.4% of tdTomato+ cells, compared to 
97.7±0.7% of cells in the adjacent perichondrium, n=3 mice), indicating that most of 
these peripheral chondrocytes were not dividing. Therefore, borderline chondrocytes can 
passively translocate to the marrow space without involving active cell proliferation. 
Neonatal borderline chondrocytes behave as transient mesenchymal precursor cells 
 We interrogated fates of PTHrPCE-P0 cells at sequential time points after the 
pulse. After 5 days of chase, PTHrPCE-P0 cells further moved into the endosteal region, 
some of which became Cxcl12-GFPhigh stromal cells in the adjacent marrow space 
This article is protected by copyright. All rights reserved. 
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(Fig.S4A). After a week of chase at P7, PTHrPCE-P0 cells became Col1(2.3kb)-GFP+ 
osteoblasts on the metaphyseal trabecular bone surface and reticular stromal cells in the 
inter-trabecular marrow space (Fig. 2H). After 9 days of chase at P9, PTHrPCE-P0 cells 
occupied a well-defined reverse triangular area of the spongiosa at the corner of the 
hypertrophic zone and the endosteal surface, demonstrating that borderline chondrocytes 
can particularly contribute to marrow mesenchymal cells of the peripheral areas (Fig. 2I). 
After two weeks of chase at P14, PTHrPCE-P0 cells continued to become Col1(2.3kb)-
GFP+ osteoblasts and Cxcl12-GFPhigh stromal cells in the metaphyseal marrow space 
(Fig. 2J, Fig.S4B). Quantification of Col1(2.3kb)-GFP+tdTomato+ and Cxcl12-
GFPhightdTomato+ cells after being pulsed at P0 or P6 demonstrated that PTHrPCE-P0 
cells, but not PTHrPCE-P6 cells, became osteoblasts and marrow stromal cells at this 
stage, indicating that these tdTomato+ cells were derived from neonatal borderline 
chondrocytes (Fig.S4C). In addition, columnar chondrocytes derived from PTHrPCE-P0 
cells resting chondrocytes had not yet reached the entire length of the growth plate at this 
stage. We further chased PTHrPCE-P0 cells for a longer period into adulthood. At 5 
weeks of chase at P36, PTHrPCE-P0 cells sporadically remained as Col1(2.3kb)-GFP+ 
osteoblasts and Cxcl12-GFPhigh stromal cells in the metaphyseal marrow space, without 
any expansion of tdTomato+ areas (Fig.S4D,E), although we could no longer discriminate 
the origin of these cells at this stage because columnar chondrocytes originating from 
these resting chondrocytes had already reached the primary spongiosa. After 9.5 weeks of 
chase at P67, a vast majority of PTHrPCE-P0 cells disappeared from the marrow space, 
with only a small number of tdTomato+ cells remaining on trabecular bone surfaces 
(Fig.S4F). Quantification of tdTomato+ cells in the marrow space revealed that PTHrPCE-
This article is protected by copyright. All rights reserved. 
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P0 cells transiently increased their number in the marrow space at P14, then drastically 
decreased their number toward P36 (Fig. 2K). Taken together, these data suggest that 
PTHrP+ borderline chondrocytes behave as mesenchymal precursor cells for osteoblasts 
and marrow stromal cells that transiently expand in the marrow space during the early 
phase of postnatal bone growth. 
Discussion 
Our lineage-tracing study provides evidence that borderline chondrocytes in the 
fetal and neonatal growth plate can generate osteoblasts and marrow stromal cells in vivo 
in a mouse model. Further, our single cell RNA-seq analysis reveals cellular identity of 
these special chondrocytes. Chondrocytes at the periphery of the growth plate appear to 
represent an important pathway to generate marrow mesenchymal cells particularly in 
rapidly growing endochondral bones (see diagram, Fig. 2L); these cells go through a 
unique state expressing Col10a1 without hypertrophy on their way to becoming 
mesenchymal cells in the marrow space. In combination with our previous finding that 
hypertrophic chondrocytes in the central growth plate can produce marrow mesenchymal 
cells predominantly in the adult stage(4), we speculate that different routes of 
chondrocytes are utilized to generate osteoblasts and marrow stromal cells in a stage-
specific manner. Additionally, our data indicate that Pthrp-creER+ borderline 
chondrocytes represent a non-self-renewing subset of Col2a1-creER+ chondrocytes; we 
observed that borderline chondrocytes-derived marrow mesenchymal cells could only 
transiently persist within the marrow space. More immature Col2a1+PTHrPneg 
chondrocytes within the growth plate such as Grem1+ cells in the upper zone(11), rather 
This article is protected by copyright. All rights reserved. 
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than immature perichondrial cells, are likely to serve as precursors for PTHrP+ borderline 
chondrocytes that continue to feed into the nascent marrow space. Additionally, Pthrp-
creER can mark perichondrial precursor cells during the fetal stage. Marked by the same 
Pthrp-creER transgene at different time points, the characteristics of PTHrP+ borderline 
chondrocytes appear to be fundamentally different from those of PTHrP+ resting 
chondrocytes that can self-renew long term within the resting zone. We speculate that 
differentiation of borderline chondrocytes occurs more effectively than 
transdifferentiation of hypertrophic chondrocytes in generating mesenchymal cells of the 
marrow space. How PTHrP+ chondrocytes at the periphery and the center are functionally 
different needs to be addressed through further studies. 
Acknowledgements 
We thank T. Nagasawa of Osaka University for providing Cxcl12-GFP mice. This 
research was supported by NIH R01DE026666 to N.O. and R03DE027421 to W.O. 
Authors’ roles: study design & conduct, data collection, analysis & interpretation: K.M., 
M.N., Y.M. and N.O. Drafting manuscript: K.M. and N.O., revising manuscript content: 
W.O. Approving final version of manuscript: K.M., M.N., Y.M., W.O. and N.O. N.O. 
takes responsibility for the integrity of the data analysis. 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved. 
 
A
ut
ho
r 
M
an
us
cr
ip
t 
References 
1. Yang L, Tsang KY, Tang HC, Chan D, Cheah KS. Hypertrophic chondrocytes 
can become osteoblasts and osteocytes in endochondral bone formation. Proc Natl 
Acad Sci U S A. Aug 2014;111(33):12097-102. Epub 2014/08/04. 
2. Ono N, Ono W, Nagasawa T, Kronenberg HM. A subset of chondrogenic cells 
provides early mesenchymal progenitors in growing bones. Nat Cell Biol. Dec 
2014;16(12):1157-67. 
3. Zhou X, von der Mark K, Henry S, Norton W, Adams H, de Crombrugghe B. 
Chondrocytes transdifferentiate into osteoblasts in endochondral bone during 
development, postnatal growth and fracture healing in mice. PLoS Genet. Dec 
2014;10(12):e1004820. Epub 2014/12/04. 
4. Mizuhashi K, Ono W, Matsushita Y, Sakagami N, Takahashi A, Saunders TL, et 
al. Resting zone of the growth plate houses a unique class of skeletal stem cells. 
Nature. Nov 2018;563(7730):254-8. Epub 2018/10/31. 
5. Bianco P, Cancedda FD, Riminucci M, Cancedda R. Bone formation via cartilage 
models: the "borderline" chondrocyte. Matrix Biol. Jul 1998;17(3):185-92. 
6. Ara T, Itoi M, Kawabata K, Egawa T, Tokoyoda K, Sugiyama T, et al. A role of 
CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth 
stimulating factor and its receptor CXCR4 in fetal and adult T cell development in 
vivo. J Immunol. May 2003;170(9):4649-55. 
This article is protected by copyright. All rights reserved. 
 
A
ut
ho
r 
M
an
us
cr
ip
t 
7. Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell 
transcriptomic data across different conditions, technologies, and species. Nat 
Biotechnol. Jun 2018;36(5):411-20. Epub 2018/04/02. 
8. Tagariello A, Luther J, Streiter M, Didt-Koziel L, Wuelling M, Surmann-Schmitt 
C, et al. Ucma--A novel secreted factor represents a highly specific marker for 
distal chondrocytes. Matrix Biol. Jan 2008;27(1):3-11. Epub 2007/07/13. 
9. Surmann-Schmitt C, Dietz U, Kireva T, Adam N, Park J, Tagariello A, et al. 
Ucma, a novel secreted cartilage-specific protein with implications in 
osteogenesis. J Biol Chem. Mar 2008;283(11):7082-93. Epub 2007/12/21. 
10. Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, et 
al. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-
arthropathy-coxa vara-pericarditis syndrome. Nat Genet. Nov 1999;23(3):319-22. 
11. Worthley DL, Churchill M, Compton JT, Tailor Y, Rao M, Si Y, et al. Gremlin 1 
identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. 
Cell. Jan 2015;160(1-2):269-84. 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved. 
 
A
ut
ho
r 
M
an
us
cr
ip
t 
Figures 
Figure 1. Single cell RNA-seq characterization of neonatal growth plate 
chondrocytes.(A,B) Cell-fate analysis of Col2a1-creER+ neonatal growth plate 
chondrocytes (P0-pulsed) at P2 (A) and P7 (B). PC: perichondrium, PZ: proliferating 
zone, HZ: hypertrophic zone. Right panels: SafraninO & FastGreen staining of identical 
sections. Arrows: tdTomato+ borderline chondrocytes, arrowheads: tdTomato+ cells in 
peripheral metaphyseal marrow space. Scale bars: 200µm (left panels), 100µm (right 
panels). n=3 mice for each experiment.(C,D) Single cell RNA-seq analysis of Col2a1-
creER+ neonatal growth plate chondrocytes. (D) t-SNE-based visualization of major 
classes of FACS-sorted Col2a1CE-tdTomato+ single cells at P2 (Cluster 0-10). Cluster 
0,5,7: lower zone column-forming chondrocytes, Cluster1,3: upper zone chondrocytes, 
Cluster 2,6: articular surface chondrocytes, Cluster 4: collagen-rich articular cells, Cluster 
8: borderline chondrocytes, Cluster 9,10: cells in cell cycle. Dots: individual cells, color: 
cell type. Green contour: borderline chondrocytes. Right panels: feature plots of Acan, 
Prg4 and Ucma. Blue: high expression, grey: no expression. n=8,486 cells.(E) In situ 
validation of the identified marker, Fosl1. Col2a1-creER; R26RtdTomato distal femurs at 
P2 (P0-pulsed). (E’,E”): tdTomato, Fosl1-Alexa488 single channel, (1-1”): magnified 
views of the dotted area. Scale bars: 200µm (E-E”), 50µm (1-1”). n=3 mice. 
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Figure 2. Pthrp-creER+ borderline chondrocytes in the neonatal stage behave as 
transient mesenchymal precursor cells.Cell-fate analysis of Pthrp-creER+ borderline 
chondrocytes (P0-pulsed) at P2 (A-F), P4 (G), P7 (H), P9 (I) and P14 (J). (A,F-J): 
Col1(2.3kb)-GFP; Pthrp-creER; R26RtdTomato distal femurs, (B-E): Pthrp-creER; 
R26RtdTomato distal femurs. (A’,G’,J’): magnified views of the dotted areas. In (B-D), left 
panels (bright field) and right panels (dark field) represent the identical sections. Right 
panels in (F): SafraninO & FastGreen staining of left panels. Arrowheads in (B-F): 
tdTomato+ borderline chondrocytes denoting identical cells. PC: perichondrium, PZ: 
proliferating zone, HZ: hypertrophic zone. Arrowheads in (H,I): tdTomato+ cells in 
peripheral metaphyseal marrow space, arrow in (J): GFP+tdTomato+ osteoblasts. Scale 
bars: 200µm (A,G), 500µm (H-J), 20µm (A-F), 50µm (J’). n=3 mice for each experiment. 
(K): Quantification of tdTomato+ marrow cells at each time point. n=6 (P2), n=4 (P4), 
n=3 (P5, P9, P14, P36) mice, data are presented as mean ± S.D. (L): Concluding diagram. 
Borderline chondrocytes in growth plates can translocate into marrow space and behave 
as transient precursors for osteoblasts and stromal cells by escaping hypertrophy and 
apoptosis. 
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